Clinical relevance of time course of BNP levels in neonates with congenital heart diseases

Clinica Chimica Acta

Volumn 412, Issue 23-24, 2011, Pages 2300-2304

  Cantinotti, Massimiliano ^a   Passino, Claudio ^a   Storti, Simona ^a   Ripoli, Andrea ^a   Zyw, Luc ^a   Clerico, Aldo ^a  

^a SCUOLA SUPERIORE SANT ANNA   (Italy)

Author keywords

B type natriuretic hormone; Congenital heart disease; Diagnostic accuracy; Immunoassay; Newborns; ROC analysis

Indexed keywords

AREA UNDER THE CURVE; ARTICLE; CONGENITAL HEART DISEASE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DISEASE COURSE; FEMALE; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; NEWBORN; ONSET AGE; PEDIATRICS; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; REFERENCE VALUE; SENSITIVITY AND SPECIFICITY;

AREA UNDER CURVE; CASE-CONTROL STUDIES; HEART DEFECTS, CONGENITAL; HUMANS; INFANT, NEWBORN; INFANT, NEWBORN, DISEASES; NATRIURETIC PEPTIDE, BRAIN;

EID: 80053645334     PISSN: 00098981     EISSN: 18733492     Source Type: Journal    
DOI: 10.1016/j.cca.2011.08.030     Document Type: Article

References (37)

1. Tang W.H., Francis G.S., Morrow D.A., et al. National Academy of Clinical Biochemistry Laboratory Medicine practice guidelines: clinical utilization of cardiac biomarker testing in heart failure. Circulation 2007, 116:e99-e109.
2. Emdin M., Vittorini S., Passino C., Clerico A. Old and new biomarkers of heart failure. Eur J Heart Fail 2009, 11:331-335.
3. Cantinotti M., Clerico A., Murzi M., Vittorini S., Emdin M. Clinical relevance of measurement of brain natriuretic peptide and N-terminal pro-brain natriuretic peptide in pediatric cardiology. Clin Chim Acta 2008, 390:12-22.
4. Nir A., Lindinger A., Rauh M., et al. NT-Pro-B-type natriuretic peptide in infants and children: reference values based on combined data from four studies. Pediatr Cardiol 2009, 30:3-8.
5. El-Khuffash A., Molloy E.J. Are B-type natriuretic peptide (BNP) and N-terminal-BNP useful in neonates?. Arch Dis Child 2007, 92:F320-F324.
6. Cantinotti M., Giovannini S., Murzi B., Clerico A. Review: diagnostic, prognostic and therapeutic relevance of B-type natriuretic peptide assay in children with congenital heart diseases. Clin Chem Lab Med 2010, 4:567-580.
7. Law Y.M., Hoyer A.W., Reller M.D., Silberbach M. Accuracy of plasma B-type natriuretic peptide to diagnose significant cardiovascular disease in children: the better not pout children! Study. J Am Coll Cardiol 2009, 54:1467-1475.
8. Socrates T., Arenja N., Mueller C. B-type natriuretic peptide in children: step by step. J Am Coll Cardiol 2009, 54:1476-1477.
9. Cantinotti M., Storti S., Crocetti M., Assanta N., Murzi B., Clerico A. Decision levels for plasma B-type natriuretic peptide assay to diagnose significant cardiovascular disease in children. J Am Coll Cardiol 2010, 55:1166-1167.
10. Cantinotti M., Storti S., Ripoli A., et al. Diagnostic accuracy of BNP assay for congenital heart disease in the first month of life. Clin Chem Lab Med 2010, 48:1333-1338.
11. Czernik C., Lemmer J., Metze B., Koehne P.S., Mueller C., Obladen M. B-type natriuretic peptide to predict ductus intervention in infants -28weeks. Pediatr Res 2008, 64:286-290.
12. Farombi-Oghuvbu I., Matthews T., Mayne P.D., Guerin H., Corcoran J.D. N-terminal pro-B-type natriuretic peptide: a measure of significant patent ductus arteriosus. Arch Dis Child 2008, 93:F257-F260.
13. Sanjeev S., Pettersen M., Lua J., Thomas R., Shankaran S., L'Ecuyer T. Role of plasma B-type natriuretic peptide in screening for hemodynamically significant patent ductus arteriosus in preterm neonates. J Perinatol 2005, 25:709-713.
14. Flynn P.A., da Graca R.L., Auld P.A., Nesin M., Kleinman C.S. The use of a bedside assay for plasma B-type natriuretic peptide as a biomarker in the management of patent ductus arteriosus in premature neonates. J Pediatr 2005, 147:38-42.
15. Choi B.M., Lee K.H., Eun B.L., et al. Utility of rapid B-type natriuretic peptide assay for diagnosis of symptomatic patent ductus arteriosus in preterm infants. Pediatrics 2005, 115:e255-e261.
16. Ko H.K., Lee J.H., Choi B.M., et al. Utility of the rapid B-type natriuretic peptide assay for detection of cardiovascular problems in newborn infants with respiratory difficulties. Neonatology 2008, 94:16-21.
17. Davlouros P.A., Karatza A.A., Xanthopoulou I., et al. Diagnostic role of plasma BNP levels in neonates with signs of congenital heart disease. Int J Cardiol 2011, 147:42-46.
18. Reynolds E.W., Ellington J.G., Vranicar M., Bada H.S. Brain-type natriuretic peptide in the diagnosis and management of persistent pulmonary hypertension of the newborn. Pediatrics 2004, 114:1297-1304.
19. Cantinotti M., Storti S., Parri M.S., Prontera C., Murzi B., Clerico A. Reference intervals for brain natriuretic peptide in healthy newborns and infants measured with an automated immunoassay platform. Clin Chem Lab Med 2010, 48:697-700.
20. Cantinotti M., Storti S., Murzi B., Clerico A. Clinical relevance of different BNP decisional cut-off values for the diagnosis of CHD in the first week of life. Pediatr Cardiol 2011, 32:537-538.
21. Cantinotti M., Storti S., Parri M.S., Murzi M., Clerico A. Reference values for plasma BNP circulating levels in the first days of life. Clin Chem 2009, 55:1438-1440.
22. Lopez L., Colan S.D., Frommelt P.C., et al. Recommendations for quantification methods during the performance of a pediatric echocardiogram: a report from the Pediatric Measurements Writing Group of the American Society of Echocardiography Pediatric and Congenital Heart Disease Council. J Am Soc Echocardiogr 2010, 23:465-495.
23. Prontera C., Storti S., Emdin M., et al. Comparison of a fully automated immunoassay with a point-of-care testing method for B-type natriuretic peptide. Clin Chem 2005, 51:1274-1276.
24. Robin X., Turck N., Hainard A., et al. pROC: an open-source package for R and S+ to analyze and compare ROC curves. BMC Bioinformatics 2011, 12:77.
25. DeLong E.R., DeLong D.M., Clarke-Pearson D.L. Comparing the areas under two or more correlated ROC curves: a nonparametric approach. Biometrics 1988, 44:837-845.
26. Rudolph A.M. Congenital cardiovascular malformation and the fetal circulation. Arch Dis Child Fetal Neonatal Ed 2010, 95:F132-F136.
27. Holmgren D., Westerlind A., Lundberg P.A., Wahlander H. Increased plasma levels of natriuretic peptide type B and A in children with congenital heart defects with left compared with right ventricular volume overload or pressure overload. Clin Physiol Funct Imaging 2005, 25:263-269.
28. Goetze J.P., Georg B., Jørgensen H.L., Fahrenkrug J. Chamber-dependent circadian expression of cardiac natriuretic peptides. Regul Pept 2010, 160:140-145.
29. Koch A., Zink S., Singer H. B-type natriuretic peptide in paediatric patients with congenital heart disease. Eur Heart J 2006, 27:861-866.
30. Cowley C.G., Bradley J.D., Shaddy R.E. B-type natriuretic peptide levels in congenital heart disease. Pediatr Cardiol 2004, 25:336-340.
31. Cannesson M., Bionda C., Gostoli B., Raisky O., di Filippo S., Bompard D., et al. Time course and prognostic value of plasma B-type natriuretic peptide concentration in neonates undergoing the arterial switch operation. Anesth Analg 2007, 104:1059-1065.
32. Mir T.S., Marohn S., Läer S., Eiselt M., Grollmus O., Weil J. Plasma concentrations of N-terminal pro-brain natriuretic peptide in control children from the neonatal to adolescent period and in children with congestive heart failure. Pediatrics 2002, 110:e76.
33. Jacobs J.P., Jacobs M.L., Lacour-Gayet F.G., et al. Stratification of complexity improves the utility and accuracy of outcomes analysis in a Multi-Institutional Congenital Heart Surgery Database: Application of the Risk Adjustment in Congenital Heart Surgery (RACHS-1) and Aristotle Systems in the Society of Thoracic Surgeons (STS) Congenital Heart Surgery Database. Pediatr Cardiol 2009, 30:1117-1130.
34. Sinha A.M., Breithardt O.A., Schmid M., Stellbrink C. Brain natriuretic peptide release in cardiac surgery patients. Thorac Cardiovasc Surg 2005, 53:138-143.
35. Bergler-Klein J. Natriuretic peptides in the management of aortic stenosis. Curr Cardiol Rep 2009, 11:85-93.
36. Talha S., Charloux A., Enache I., Piquard F., Geny B. Mechanisms involved in increased plasma brain natriuretic peptide after heart transplantation. Cardiovasc Res 2011, 89:273-281.
37. Prontera C., Zaninotto M., Giovannini S., et al. Proficiency testing project for brain natriuretic peptide (BNP) and the N-terminal part of the propeptide of BNP (NT-proBNP) immunoassays: the CardioOrmocheck study. Clin Chem Lab Med 2009, 47:762-768.